Tao Ma

Tao Ma

Auto-generated profile, based on publicly available information

Tao Ma

Department of Anesthesiology PLA Rocket Force Characteristic Medical Center Beijing China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YWYing-Ying Wang
Ying-Ying Wang
HZHao Zhang
Hao Zhang
TMTao Ma
Tao Ma
YLYan Lu
Yan Lu
HXHou-Yun Xie
Hou-Yun Xie
YLYong-Wang Li
Yong-Wang Li

3 March 2020 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
YYYitian Yang
Yitian Yang
YSYuxiang Song
Yuxiang Song
XZXuan Zhang
Xuan Zhang
WZWeixing Zhao
Weixing Zhao
TMTao Ma
Tao Ma
HZHong Zhang
Hong Zhang

10 March 2020 in Brain and Behavior
Verified
Journal Article
Open access
PDF file
TMTao Ma
Tao Ma
HZHao Zhang
Hao Zhang
ZXZhi‐Peng Xu
Zhi‐Peng Xu
YLYan Lu
Yan Lu
QFQiang Fu
Qiang Fu
WMWeidong Mi
Weidong Mi
Introduction: The mechanisms underlying sleep deprivation‐induced memory impairments and relevant compensatory signaling pathways remain elusive. We tested the hypothesis that increased brain‐derived neurotrophic factor (BDNF) expression in the basal forebrain following acute sleep deprivation was a compensatory mechanism to maintain fear memory performance.Methods: Adult male Wistar rats were deprived of 6‐hr total sleep from the beginning of the light cycle. The effects of sleep deprivation on BDNF protein expression and activation of downstream tropomyosin receptor kinase B (TrkB)/phospholipase C‐γ1 (PLCγ1) signaling in the basal forebrain and fear memory consolidation were examined. BDNF or selective downstream TrkB receptor antagonist ANA‐12 was further injected into the basal forebrain bilaterally to observe the changes in fear memory consolidation in response to modulation of the BDNF/TrkB signaling.Results: Six hours of sleep deprivation‐induced both short‐ and long‐term fear memory impairments. Increased BDNF protein expression and TrkB and PLCγ1 phosphorylation in the basal forebrain were observed after sleep deprivation. Microinjection of BDNF into the basal forebrain partly reversed fear memory deficits caused by sleep deprivation, which were accompanied by increased BDNF protein levels and TrkB/PLCγ1 activation. After ANA‐12 microinjection, sleep deprivation‐induced activation of the BDNF/TrkB pathway was inhibited and impairments of fear memory consolidation were further aggravated.Conclusions: Acute sleep deprivation induces compensatory increase of BDNF expression in the basal forebrain. Microinjection of BDNF into the basal forebrain mitigates the fear memory impairments caused by sleep deprivation by activating TrkB/PLCγ1 signaling.

22 September 2021 in Behavioural Brain Research
Verified
Journal Article
Open access
TMTao Ma
Tao Ma
YWYing-Ying Wang
Ying-Ying Wang
YLYan Lu
Yan Lu
LFLong Feng
Long Feng
YYYitian Yang
Yitian Yang
HZHao Zhang
Hao Zhang
In this study, we tested the hypothesis that the Piezo1/Ca2+/calpain pathway of the basal forebrain (BF) modulates impaired fear conditioning caused by sleep deprivation. Adult male Wistar rats were subjected to 6 h of total sleep deprivation using the gentle handling protocol. Step-down inhibitory avoidance tests revealed that sleep deprivation induced substantial short- and long-term fear memory impairment in rats, which was accompanied by increased Piezo1 protein expression (P < 0.01) and increased cleavage of full-length tropomyocin receptor kinase B (TrkB-FL) (P < 0.01) in the BF area. Microinjection of the Piezo1 activator Yoda1 into the BF mimicked these sleep deprivation-induced phenomena; TrkB-FL cleavage was increased (P < 0.01) and short- and long-term fear memory was impaired (both P < 0.01) by Yoda1. Inhibition of Piezo1 by GsMTx4 in the BF area reduced TrkB-FL degradation (P < 0.01) and partially reversed short- and long-term fear memory impairments in sleep-deprived rats (both P < 0.01). Inhibition of calpain activation, downstream of Piezo1 signaling, also improved short- and long-term fear memory impairments (P = 0.038, P = 0.011) and reduced TrkB degradation (P < 0.01) in sleep-deprived rats. Moreover, sleep deprivation induced a lower pain threshold than the rest control, which was partly reversed by microinjection of GsMTx4 or PD151746. Neither sleep deprivation nor the abovementioned drugs affected locomotion and sedation. Taken together, these results indicate that BF Piezo1/Ca2+/calpain signaling plays a role in sleep deprivation-induced TrkB signaling disruption and fear memory impairments in rats.

1 April 2016 in Chinese Journal of Natural Medicines
Verified
Journal Article
Closed access
SYSi-Yuan Yuan
Si-Yuan Yuan
TSTong Sheng
Tong Sheng
LLLian-Qi Liu
Lian-Qi Liu
YZYunling Zhang
Yunling Zhang
XLXue-Mei Liu
Xue-Mei Liu
XWXin-Xiang Wang
Xin-Xiang Wang

18 April 2023 in Brain and Behavior
Verified
Journal Article
Open access
TMTao Ma
Tao Ma
LFLong Feng
Long Feng
SWShi‐Nan Wei
Shi‐Nan Wei
YWYing‐Ying Wang
Ying‐Ying Wang
GLGuan‐Hua Li
Guan‐Hua Li
HZHao Zhang
Hao Zhang
Introduction: Regulation of brain‐derived neurotrophic factor (BDNF) in the basal forebrain ameliorates sleep deprivation‐induced fear memory impairments in rodents. Antisense oligonucleotides (ASOs) targeting ATXN2 was a potential therapy for spinocerebellar ataxia, whose pathogenic mechanism associates with reduced BDNF expression. We tested the hypothesis that ASO7 targeting ATXN2 could affect BDNF levels in mouse basal forebrain and ameliorate sleep deprivation‐induced fear memory impairments.Methods: Adult male C57BL/6 mice were used to evaluate the effects of ASO7 targeting ATXN2 microinjected into the bilateral basal forebrain (1 μg, 0.5 μL, each side) on spatial memory, fear memory and sleep deprivation‐induced fear memory impairments. Spatial memory and fear memory were detected by the Morris water maze and step‐down inhibitory avoidance test, respectively. Immunohistochemistry, RT‐PCR, and Western blot were used to evaluate the changes of levels of BDNF, ATXN2, and postsynaptic density 95 (PSD95) protein as well as ATXN2 mRNA. The morphological changes in neurons in the hippocampal CA1 region were detected by HE staining and Nissl staining.Results: ASO7 targeting ATXN2 microinjected into the basal forebrain could suppress ATXN2 mRNA and protein expression for more than 1 month and enhance spatial memory but not fear memory in mice. BDNF mRNA and protein expression in basal forebrain and hippocampus was increased by ASO7. Moreover, PSD95 expression and synapse formation were increased in the hippocampus. Furthermore, ASO7 microinjected into the basal forebrain increased BDNF and PSD95 protein expression in the basal forebrain of sleep‐deprived mice and counteracted sleep deprivation‐induced fear memory impairments.Conclusion: ASOs targeting ATXN2 may provide effective interventions for sleep deprivation‐induced cognitive impairments.